Optimizing transfusion therapy in the chronically transfused patient

No abstract is available for this paper.

• Publication year

  2016

• Venue

  ISBT Science Series

• Publication date

  2016-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/voxs.12241
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia

  2014cited by this paper
• Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing

  2014cited by this paper
• Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT)

  2014cited by this paper
• Prophylactic Rh and Kell Antigen Matching Significantly Decreases Rates of Alloimmunization in Transfusion Dependent MDS Patients

  2014cited by this paper
• Guidelines for the Management of Non Transfusion Dependent Thalassaemia (NTDT)

  2013cited by this paper
• Challenges of alloimmunization in patients with haemoglobinopathies

  2012cited by this paper
• Haemoglobinopathies in Southeast Asia

  2011cited by this paper
• Optimal management of β thalassaemia intermedia

  2011cited by this paper
• Red cell alloimmunization in a diverse population of transfused patients with thalassaemia

  2011cited by this paper
• Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods

  2008cited by this paper
• Red cell immunization in multiply transfused Malay thalassemic patients.

  2006cited by this paper
• Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study

  2005cited by this paper
• Alloimmunization in Hong Kong southern Chinese transfusion-dependent thalassemia patients.

  2001cited by this paper
• Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent.

  2000cited by this paper
• Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases

  1999cited by this paper
• A moderate transfusion regimen may reduce iron loading in beta‐ thalassemia major without producing excessive expansion of erythropoiesis

  1997cited by this paper
• Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.

  1997cited by this paper
• Relationship between transfusion regimen and suppression of erythropoiesis in β‐thalassaemia major

  1995cited by this paper
• Red Cell Alloantibodies in Patients with Thalassemia

  1990cited by this paper
• Alloimmunization to Red Cell Antigens in Thalassemia: Comparative Study of Usual versus Better‐Match Transfusion Programmes

  1987cited by this paper
• Immune Response to Chronic Red Blood Cell Transfusion

  1983cited by this paper

• The transfusion management of beta thalassemia in the United States

  2021cites this paper